Usageanddosageofberyutong®enoxaparinsodiuminjectionTumorVTEprophylaxisInpatient/outpatientOnceaday,anticoagulanttherapyshouldbefollowedthroughoutthedurationofthehospitalizationwithheparinsodium4000IUS
VTEintumorpatientsPatientswithDeepVeinThrombosisDVTshouldbetreatedwithenoxaparinformorethan3to6months.AndthepatientthatamalgamatesPEshouldaccept6~12monthsofabovetreatment.Indefiniteanticoagulanttherap
Comparedtonon-cancerpatientswhounderwentsimilarsurgeryTheriskofVTEincancerpatientsis4-6timeshigherthaninnon-cancerpatientsPatientsreceivingchemotherapyhada6.5foldincreasedriskofVTETheriskofDVTincancer
Heparinsodiumindustrytrendsstudymainlyonthebasisofthenationalbureauofstatistics,thegeneraladministrationofcustoms,thenationaldevelopmentandreformcommission,theministryofcommerce,thestateministryofindu